Protagenic Therapeutics, Inc.\new - Common Stock, par value $0.0001 per share (PTIX)

Historical Holders from Q1 2023 to Q2 2025

Symbol
PTIX on Nasdaq
CUSIP
74365N202
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
870K
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-8
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Protagenic Therapeutics, Inc.\new - Common Stock, par value $0.0001 per share (PTIX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 3.41% $72K 240K Armistice Capital, LLC Dec 31, 2024

Institutional Holders of Protagenic Therapeutics, Inc.\new - Common Stock, par value $0.0001 per share (PTIX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$65.9K 0
2025 Q1 338K $65.9K +$26K $0.20 8
2024 Q4 150K $78K -$13.1K $0.50 8
2024 Q3 165K $104K -$9.59K $0.63 9
2024 Q2 160K $146K +$38K $0.91 10
2024 Q1 118K $206K +$19.7K $1.75 9
2023 Q4 113K $107K +$15.7K $0.99 9
2023 Q3 96.4K $179K -$2.01K $1.87 8
2023 Q2 97.2K $198K +$3.64K $2.03 9
2023 Q1 94K $162K +$162K $1.73 9